NO20002990L - Nytt overflateprotein - Google Patents

Nytt overflateprotein

Info

Publication number
NO20002990L
NO20002990L NO20002990A NO20002990A NO20002990L NO 20002990 L NO20002990 L NO 20002990L NO 20002990 A NO20002990 A NO 20002990A NO 20002990 A NO20002990 A NO 20002990A NO 20002990 L NO20002990 L NO 20002990L
Authority
NO
Norway
Prior art keywords
surface protein
new surface
new
protein
Prior art date
Application number
NO20002990A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002990D0 (no
Inventor
Ian Richard Anselm Peak
Michael Paul Jennings
E Richard Moxon
Original Assignee
Univ Queensland
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10823587&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20002990(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Queensland, Isis Innovation filed Critical Univ Queensland
Publication of NO20002990D0 publication Critical patent/NO20002990D0/no
Publication of NO20002990L publication Critical patent/NO20002990L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20002990A 1997-12-12 2000-06-09 Nytt overflateprotein NO20002990L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726398.2A GB9726398D0 (en) 1997-12-12 1997-12-12 Polypeptide and coding sequences
PCT/AU1998/001031 WO1999031132A1 (en) 1997-12-12 1998-12-14 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS)

Publications (2)

Publication Number Publication Date
NO20002990D0 NO20002990D0 (no) 2000-06-09
NO20002990L true NO20002990L (no) 2000-08-08

Family

ID=10823587

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002990A NO20002990L (no) 1997-12-12 2000-06-09 Nytt overflateprotein

Country Status (17)

Country Link
US (8) US6197312B1 (pl)
EP (2) EP2354230A1 (pl)
JP (2) JP4356961B2 (pl)
KR (1) KR100571533B1 (pl)
CN (2) CN101684148A (pl)
AU (1) AU747742B2 (pl)
BR (1) BR9814276A (pl)
CA (1) CA2314319C (pl)
CZ (1) CZ299646B6 (pl)
GB (1) GB9726398D0 (pl)
HU (1) HUP0100094A3 (pl)
IL (2) IL136684A0 (pl)
NO (1) NO20002990L (pl)
NZ (1) NZ505374A (pl)
PL (1) PL205984B1 (pl)
TR (1) TR200001709T2 (pl)
WO (1) WO1999031132A1 (pl)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
WO1999036544A2 (en) * 1998-01-14 1999-07-22 Chiron S.P.A. Neisseria meningitidis antigens
FR2776928B1 (fr) * 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
EP2261347A3 (en) 1998-05-01 2012-01-11 Novartis Vaccines and Diagnostics, Inc. Neisseria meningitidis antigens and compositions
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
CA2372235A1 (en) 1999-04-30 2000-11-09 Rino Rappuoli Conserved neisserial antigens
AU2004240199B2 (en) * 1999-04-30 2007-05-17 Novartis Vaccines And Diagnostics S.R.L. Conserved Neisserial antigens
BR0010303A (pt) * 1999-05-04 2002-02-13 Monsanto Technology Llc Composições de polipeptìdeos tóxicas para os coleópteros e plantas transgênicas resistentes aos insetos
AU783894B2 (en) * 1999-05-19 2005-12-22 Novartis Vaccines And Diagnostics S.R.L. Combination neisserial compositions
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
EP1226253A2 (en) * 1999-10-29 2002-07-31 Chiron S.P.A. Neisserial antigenic peptides
GB9928196D0 (en) * 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
EP1234039A2 (en) 1999-11-29 2002-08-28 Chiron Spa 85kDa NEISSERIAL ANTIGEN
CA2871789C (en) 2000-01-17 2017-04-04 Novartis Vaccines And Diagnostics S.R.L. Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
MXPA02007184A (es) 2000-01-25 2004-02-26 Univ Queensland Proteinas que comprenden regiones conservadas de antigenos de superficie nhha de neisseria meningitidis.
AU2005202972B2 (en) * 2000-01-25 2008-04-24 The University Of Queensland Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
DK1947187T5 (da) 2000-02-28 2011-10-24 Novartis Vaccines & Diagnostic Hybrid ekspression af neisserial-proteiner
NO20002828D0 (no) * 2000-06-02 2000-06-02 Statens Inst For Folkehelse Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
ATE469915T1 (de) 2001-07-27 2010-06-15 Novartis Vaccines & Diagnostic Antikörper gegen das meningokokken adhäsin app
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
GB0129007D0 (en) * 2001-12-04 2002-01-23 Chiron Spa Adjuvanted antigenic meningococcal compositions
CA2493124C (en) * 2002-08-02 2014-04-29 Glaxosmithkline Biologicals S.A. Vaccine
BR0313100A (pt) * 2002-08-02 2005-06-21 Glaxosmithkline Biolog Sa Composição imunogênica, composição imunogênica isolada, vacina, método de tratamento ou prevenção de doença bacteriana gram-negativa, uso da vacina, cepa bacteriana gram-negativa geneticamente manipulada, método para preparar a composição imunogênica, método para preparar a vacina, método de preparar uma imunoglobulina para uso na prevenção ou tratamento de infecção neisserial, preparação de imunoglobulina, preparação farmacêutica, e, uso da preparação farmacêutica
CN1809380B (zh) 2002-10-11 2010-05-12 启龙有限公司 广泛防御高毒性脑膜炎球菌谱系的多肽-疫苗
MXPA05004528A (es) 2002-11-01 2005-07-26 Glaxosmithkline Biolog Sa Composicion inmunogenica.
ATE474595T1 (de) 2003-10-02 2010-08-15 Glaxosmithkline Biolog Sa B. pertussis antigene und ihre verwendung bei der vakzinierung
NZ546430A (en) 2003-10-02 2009-04-30 Novartis Vaccines & Diagnostic Liquid vaccines for multiple meningococcal serogroups
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
TW200800235A (en) 2005-10-18 2008-01-01 Otsuka Pharma Co Ltd Carrier composition for nucleic acid transport
DE602007003596D1 (de) 2006-06-12 2010-01-14 Glaxosmithkline Biolog Sa Impfstoff
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
CL2008002961A1 (es) 2007-10-04 2009-05-08 Bio Arch Lab Inc Metodo para convertir un monosacarido u oligosacarido apropiado en un quimico generico que comprende contactar dichos moleculas con un sistema microbiano que comprende uno o mas genes que codifican y expresan una via de biosintesis.
CA2705564C (en) * 2007-11-19 2014-06-10 The Procter & Gamble Company Apparatus for activating a web
KR20100119877A (ko) * 2008-01-28 2010-11-11 바이오 아키텍쳐 랩, 인크. 단리된 알코올 디하이드로게나제 효소 및 이의 용도
RU2477145C2 (ru) 2008-05-30 2013-03-10 ДЗЕ Ю.Эс.Эй., ЭС РЕПРЕЗЕНТЕД БАЙ ДЗЕ СЕКРЕТАРИ ОФ ДЗЕ АРМИ, ОН БЕХАФ ОФ УОЛТЕР РИД АРМИ Мультивалентная вакцина из нативных везикул наружной мембраны менингококков, способы ее получения и применения
EP2544714A1 (en) 2010-03-10 2013-01-16 GlaxoSmithKline Biologicals S.A. Vaccine composition
BR112012022800A2 (pt) 2010-03-11 2018-05-15 Glaxosmithkline Biologicals Sa composição imunogênica ou vacina, cepa bacteriana gram-negativa geneticamente engenheirada, métodos para o tratamento ou prevenção de infecção ou doença, para produzir uma composição imunogênica ou uma vacina, e para preparar uma imunoglobulina, preparação da imunoglobulina, e, preparação farmacêutica
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
BR112013005626B1 (pt) 2010-09-10 2022-07-26 Glaxosmithkline Biologicals Sa Meningococo, processo para a preparação de uma cepa meningocócica, vesículas de membrana externa, composição farmacêutica imunogênica, e, uso de uma composição
MX357538B (es) 2012-06-14 2018-07-13 Novartis Ag Vacunas para meningococo de serogrupo x.
CZ304288B6 (cs) * 2013-06-12 2014-02-12 Rieter Cz S.R.O. Způsob a zařízení ke sledování lineárního útvaru

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849338A (en) 1982-07-16 1989-07-18 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4843000A (en) 1979-12-26 1989-06-27 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4550081A (en) 1980-05-19 1985-10-29 The Board Of Trustees Of The Leland Stanford Jr. University Non-reverting salmonella
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4769240A (en) * 1980-09-15 1988-09-06 Bactex, Inc. Pili of neisseria and vaccine compositions containing same
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4702911A (en) * 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
JPH01125328A (ja) 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン
US5785973A (en) 1988-02-01 1998-07-28 Praxis Biologics, Inc. Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
US5144847A (en) 1988-03-24 1992-09-08 Johann Zach Pressure or force measuring device
JP3532563B2 (ja) * 1990-08-23 2004-05-31 ザ ユニバーシティー オブ ノースカロライナ アット チャペル ヒル Ｎｅｉｓｓｅｒｉａ ｇｏｎｏｒｒｈｏｅａｅおよびＮｅｉｓｓｅｒｉａ ｍｅｎｉｎｇｉｔｉｄｉｓ由来トランスフェリン結合蛋白質
FR2682041B1 (fr) 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
IL117483A (en) 1995-03-17 2008-03-20 Bernard Brodeur MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
US5646259A (en) 1995-03-24 1997-07-08 St. Louis University DNA encoding haemophilus adhesion proteins
US6143495A (en) 1995-11-21 2000-11-07 Yale University Unimolecular segment amplification and sequencing
CU22559A1 (es) 1996-01-17 1999-05-03 Ct Ingenieria Genetica Biotech Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
GB9726398D0 (en) 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
WO1999036544A2 (en) 1998-01-14 1999-07-22 Chiron S.P.A. Neisseria meningitidis antigens
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds

Also Published As

Publication number Publication date
PL205984B1 (pl) 2010-06-30
US8067004B2 (en) 2011-11-29
US20090270591A1 (en) 2009-10-29
BR9814276A (pt) 2000-10-03
JP2009045071A (ja) 2009-03-05
US20120123093A1 (en) 2012-05-17
HUP0100094A3 (en) 2003-08-28
US20020102276A1 (en) 2002-08-01
NZ505374A (en) 2002-03-01
US6495345B1 (en) 2002-12-17
TR200001709T2 (tr) 2001-03-21
NO20002990D0 (no) 2000-06-09
WO1999031132A1 (en) 1999-06-24
CA2314319C (en) 2013-08-13
IL199175A (en) 2013-07-31
CA2314319A1 (en) 1999-06-24
PL341160A1 (en) 2001-03-26
JP4356961B2 (ja) 2009-11-04
EP1045859A1 (en) 2000-10-25
US20100331537A1 (en) 2010-12-30
CN1284965A (zh) 2001-02-21
CZ20002172A3 (cs) 2000-11-15
JP4651703B2 (ja) 2011-03-16
EP1045859A4 (en) 2001-08-22
EP2354230A1 (en) 2011-08-10
JP2002508394A (ja) 2002-03-19
US20050058660A1 (en) 2005-03-17
US8034358B2 (en) 2011-10-11
CN101684148A (zh) 2010-03-31
AU747742B2 (en) 2002-05-23
US6607729B2 (en) 2003-08-19
US20130085262A1 (en) 2013-04-04
HUP0100094A1 (hu) 2001-05-28
IL136684A0 (en) 2001-06-14
AU1649599A (en) 1999-07-05
US6197312B1 (en) 2001-03-06
GB9726398D0 (en) 1998-02-11
CZ299646B6 (cs) 2008-10-01
KR100571533B1 (ko) 2006-04-14
KR20010033074A (ko) 2001-04-25

Similar Documents

Publication Publication Date Title
DE19810476B4 (de) Laryngomaske
ATA93198A (de) Fluoxetinpellets
DE69815952D1 (de) Poliergerät
PT1036083E (pt) Novos 9a-azalidos
DE69816146D1 (de) Poliervorrichtung
DE59803185D1 (de) Baulaser
ATA111897A (de) Kimme
DE59802506D1 (de) Weichspülmittelzusammemsetzung
DE69838161D1 (de) Poliervorrichtung
DE59801498D1 (de) Dioxacycloalkan-8-one
DE59710388D1 (de) Mikropolarimeter
ATE295417T1 (de) Angiostatin-bindendes protein
DK0983266T3 (da) Hidtil ukendte tetrahydrosioquinolinthiophencarboximidamider
ATE236897T1 (de) 3-benzylpiperidine
ATA112597A (de) Snowboard - bindung
EP0949331A4 (en) Established microglial cells
DK1005511T3 (da) Overfladebehandling
ATA46498A (de) Kunststoffgleitbahn
DE59800820D1 (de) Stiellose kniegelenkendoprothese
BR9701194A (pt) Hidrociclo
FI970511A0 (fi) Lutbart plan
ITMI972543A0 (it) Proteina p27bbp
DK1088069T3 (da) Angiostatin-bindende protein
SE9702094D0 (sv) Kantblock
ATE421585T1 (de) Motlinhomologe

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application